Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020 Nov 12, 2020 09:00AM
Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020 Nov 12, 2020 08:59AM
Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal� Aug 13, 2020 09:00AM
Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal� Aug 13, 2020 09:00AM
Zealand Pharma completes the acquisition of Valeritas Apr 2, 2020 08:38AM


Apr 2, 2020 08:38AM Zealand Pharma completes the acquisition of Valeritas
Mar 20, 2020 11:13AM Valeritas Receives Court Approval of Sale of Business to Zealand Pharma
Feb 10, 2020 05:52AM Zealand Pharma (ZEAL) Reports Bid to Acquire Valeritas for $23M
Feb 9, 2020 08:40PM Zealand Pharma announces bid to acquire Valeritas
Feb 9, 2020 08:40PM Zealand Pharma announces bid to acquire Valeritas
Feb 9, 2020 08:21PM Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees